Research
Energy balance
Cagrilintide monotherapy weight loss was comparable to semaglutide.
Cagrilintide may be a viable alternative to semaglutide for weight management in obese patients.
StrongSupportsmedium confidence
Cagrilintide monotherapy weight loss was comparable to semaglutide.
Why this rating
Based on a systematic review and meta-analysis of randomized controlled trials.
Source
Efficacy and Safety of Cagrilintide and Cagrisema Versus Semaglutide as Anti‐Obesity Medications: A Systematic Review, Meta‐Analysis and Meta‐Regression
Muhammad Ahmed et al. · Diabetes Obesity and Metabolism · 2026
DOI 10.1111/dom.70667
Meta-analysis
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →